1. $1.3 Billion from NIH SBIR/STTR
The National Institutes of Health (NIH) invites small businesses to apply for the upcoming deadlines of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, with submissions due on January 5 and April 5, 2025. These programs offer critical funding to support innovative health-related research and development.
Phase I grants, aimed at early-stage, proof-of-concept projects, award up to $314,363 over 6-12 months. Successful Phase I projects may advance to Phase II, where they can receive up to $2.09 million for further development over two years. These awards provide essential support to small businesses developing solutions to address key health challenges, enabling the commercialization of breakthroughs that can benefit public health nationwide.
Read more here →
2. $1.8 Million from CDMRP
he Department of Defense’s Congressionally Directed Medical Research Programs (CDMRP) has issued a pre-announcement for the Fiscal Year 2025 (FY25) Peer Reviewed Alzheimer’s Research Program (PRARP). This program is dedicated to funding impactful, solution-oriented research that addresses critical needs and enhances the quality of life for Service Members, Veterans, and the broader public affected by Alzheimer’s disease and related dementias (AD/ADRD).
The PRARP emphasizes research in the following focus areas:
- Prevention and Risk Reduction: Investigating strategies to identify and mitigate risk factors associated with AD/ADRD, particularly those linked to military service and traumatic brain injury (TBI).
- Diagnostics, Prognostics, and Environmental Factors: Developing technologies and methods to improve the detection and understanding of AD/ADRD, including the examination of environmental influences.
- Individual, Family, and Care Support: Creating interventions and tools to support individuals living with AD/ADRD and their caregivers, with a special focus on the unique challenges faced by military families.
While the exact funding amounts and application deadlines will be detailed in the forthcoming official funding opportunity announcements, researchers are encouraged to begin preparing their proposals in anticipation of these opportunities.
Read more here.
Featured Winner
MelliCell Inc. award $275K from NIH
MelliCell Inc., headquartered in Newton, Massachusetts, is a pioneering biotechnology company specializing in adipocyte-based therapies for chronic diseases. In October 2024, MelliCell was awarded a prestigious Small Business Innovation Research (SBIR) grant from the National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK). This funding supports their collaboration with Mass General Brigham to advance innovative treatments targeting diabetes and obesity. MelliCell’s core technology enables the generation of mature human fat tissue at scale, unlocking potential for novel biologic drugs and therapeutic interventions. This grant underscores MelliCell’s commitment to addressing chronic diseases through cutting-edge adipocyte therapies
Read more here →